Lyka Labs quarterly results and financials

Lyka Labs (LYKALABS)₹80.60+0.62%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Lyka Labs reported sales of ₹44.38 Cr, up 20.6% from Sep 2025, and net profit of ₹1.28 Cr. For the year to Mar 2026, sales were ₹128 Cr and net profit −₹10.01 Cr.

Sales (Sep 2026): ₹44.38 Cr
Net profit (Sep 2026): ₹1.28 Cr
Sales (FY Mar 2026): ₹128 Cr
Net profit (FY Mar 2026): −₹10.01 Cr
EPS (Sep 2026): ₹0.37
Borrowings (Mar 2026): ₹48.92 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Lyka Labs quarterly results

₹ crore unless stated; each column is a quarter.

Lyka Labs Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	32.67	27.85	30.22	41.32	33.93	33.54	33.15	36.80	30.85	28.13	42.45	44.38
Expenses	25.68	25.72	26.39	36.22	28.59	29.32	29.33	39.21	29.07	34.47	37.74	40.69
Operating Profit	6.88	2.03	3.72	4.96	5.20	4.09	3.69	−2.53	1.66	−6.46	4.56	3.53
OPM %	21.2%	7.3%	12.4%	12.1%	15.4%	12.3%	11.2%	−6.9%	5.4%	−22.9%	10.8%	8.0%
Other Income	0.53	0.31	0.55	0.02	0.82	0.81	0.62	1.08	1.15	0.60	0.41	0.61
Interest	1.27	1.06	0.64	0.53	0.60	0.46	0.84	0.78	0.81	0.69	1.00	1.01
Depreciation	2.83	2.89	1.75	1.75	1.82	1.41	2.10	2.14	2.14	2.03	2.00	2.04
Profit before tax	3.30	−1.64	1.87	2.69	3.59	3.02	1.36	−4.40	−0.17	−8.60	1.96	1.08
Tax %	38.6%	28.2%	30.6%	28.3%	24.2%	32.8%	26.6%	−26.7%	−6.3%	−6.1%	−5.2%	−18.8%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	1.79	−2.10	1.30	1.92	2.71	2.04	1.00	−3.23	−0.16	−8.08	2.06	1.28
EPS (Rs)	0.55	−0.62	0.41	0.58	0.77	0.51	0.27	−0.93	0.00	−2.12	0.56	0.37

Lyka Labs profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Lyka Labs Profit and loss
	Mar 2016 9m	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	130	110	60.18	71.28	61.25	86.24	195	93.26	111	138	128	146
Expenses	110	86.91	62.98	72.93	65.02	66.99	92.99	76.01	94.89	121	132	142
Operating Profit	20.02	23.03	−4.01	−2.01	−4.01	20.02	101	17.02	16.01	18.03	−3.01	3.29
OPM %	16.1%	21.1%	−6.0%	−2.7%	−5.9%	23.1%	52.1%	18.1%	14.1%	13.1%	−2.7%	2.3%
Other Income	7.98	−1.99	3.99	0.99	−29.91	0.00	−3.99	−3.98	0.99	1.99	3.98	2.77
Interest	14.96	18.95	9.98	6.98	19.97	25.94	19.97	11.97	4.99	1.99	2.99	3.51
Depreciation	8.97	9.97	10.96	6.98	7.98	7.98	16.94	13.95	12.96	6.98	7.97	8.21
Profit before tax	4.01	−8.02	−20.05	−15.04	−62.17	−14.02	59.14	−13.04	−1.01	11.02	−12.02	−5.73
Tax %	−5.0%	−19.1%	−5.0%	−59.1%	1.0%	−29.0%	34.9%	0.0%	182.0%	29.0%	−11.1%	—
Exceptional items	4.01	−4.01	2.01	−1.01	−33.06	−1.01	−4.01	−7.01	0.00	0.00	0.00	0.00
Net Profit	4.01	−7.01	−19.01	−6.01	−63.08	−10.01	38.01	−13.01	−3.01	8.01	−10.01	−4.90
EPS (Rs)	1.68	−2.50	−6.13	−1.96	−21.09	−4.04	13.60	−4.31	−0.74	2.25	−2.80	−1.19
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Lyka Labs balance sheet

₹ crore, at each year end.

Lyka Labs Balance sheet
	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	21.99	21.98	21.98	27.97	27.98	29.02	28.99	29.00	30.94	32.98	35.92	35.95
Reserves	19.95	21.95	15.96	20.94	14.96	−43.11	−54.14	−15.04	14.96	34.91	68.77	56.85
Borrowings	137	121	126	113	95.90	141	163	130	74.85	58.95	38.90	48.92
Other Liabilities	99.52	76.63	87.57	66.68	75.63	72.65	51.76	41.80	30.85	29.86	31.84	32.84
Total Liabilities	278	241	251	228	215	200	190	186	152	157	175	175
Fixed Assets	122	104	133	116	108	105	97.62	93.76	67.79	57.83	84.67	86.71
CWIP	27.08	30.08	24.04	28.06	31.05	28.07	26.05	18.03	16.02	23.06	1.01	2.01
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	130	107	93.71	84.73	76.80	67.80	65.90	73.88	66.79	75.81	89.75	85.84
Inventories	19.19	10.77	13.19	11.15	6.98	6.71	4.29	8.17	6.92	9.53	12.42	13.58
Trade receivables	56.83	43.41	29.23	20.55	14.66	8.06	8.69	18.48	20.17	27.06	43.18	35.09
Cash & equivalents	6.49	5.55	5.11	2.42	1.70	10.27	7.14	16.99	11.68	5.94	1.33	1.35
Total Assets	278	241	251	228	215	200	190	186	152	157	175	175

Lyka Labs cash flow

₹ crore, for each year.

Lyka Labs Cash flow
	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	27.07	12.01	31.04	11.02	27.06	5.01	9.02	79.15	9.02	2.01	2.01	5.01
Cash from investing activity	36.89	16.95	−12.96	−2.99	−3.99	0.00	0.00	−5.98	6.98	−8.98	−11.97	−8.97
Cash from financing activity	−60.16	−30.07	−19.06	−10.02	−23.08	3.01	−12.03	−63.16	−22.05	2.01	5.01	4.01
Net cash flow	3.99	−0.99	0.00	−2.99	−1.01	9.01	−3.01	9.99	−5.01	−6.01	−5.01	0.00
Capex	6.81	5.02	13.40	3.61	4.83	1.11	1.26	7.52	8.18	9.24	15.66	11.14
Free cash flow	55.10	28.05	18.04	7.01	23.04	4.01	8.01	72.07	15.03	−7.01	−10.01	−6.01
CFO / OP %	97.0%	60.0%	143.0%	−318.0%	−1,462.0%	−131.0%	49.0%	79.0%	52.0%	21.0%	28.0%	−159.0%

Lyka Labs ratios

Working-capital days and returns, by year.

Lyka Labs Ratios
	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	123	120	96	124	74	47	36	34	78	88	113	99
Inventory days	77	56	90	139	65	69	41	56	68	78	82	99
Days payable	219	217	265	300	215	191	140	95	90	97	97	121
Cash conversion cycle	−18	−41	−79	−37	−75	−76	−63	−5	55	68	97	76
Working capital days	−220	−242	−357	−735	−265	−242	−118	−121	0	23	51	23
ROCE %	10.0%	7.0%	9.0%	−8.0%	−5.0%	−6.0%	10.0%	61.1%	5.0%	4.0%	10.1%	−6.0%

Lyka Labs: frequently asked questions

What are the latest quarterly results of Lyka Labs?

For the Sep 2026 quarter, Lyka Labs reported sales of ₹44.38 Cr, up 20.6% year on year and net profit of ₹1.28 Cr. The operating margin was 8.0%.

What is the annual revenue of Lyka Labs?

Lyka Labs' sales for the year to Mar 2026 were ₹128 Cr; over the last twelve months they were ₹146 Cr.

What is the net profit of Lyka Labs?

Net profit for the year to Mar 2026 was −₹10.01 Cr, and −₹4.90 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.19.

How much debt does Lyka Labs have?

Lyka Labs reported borrowings of ₹48.92 Cr at Mar 2026, against cash and equivalents of ₹1.35 Cr.

What is the free cash flow of Lyka Labs?

Cash from operations was ₹5.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹6.01 Cr.

Loading…